THIS PAGE HAS BEEN ARCHIVED AND IS NO LONGER UPDATED.
We apologize for the inconvenience.
To find similar material or the current version of the page, please visit one the following resources:
Health Topics || Country Sites || News Releases || Our New Homepage


ESTA PÁGINA HA SIDO ARCHIVADA Y YA NO ES ACTUALIZADA.
Pedimos disculpas por la molestia.
Para encontrar material similar o una versión actualizada de la página, visite uno de los siguientes recursos:
Temas de salud || Sitios de países || Comunicados de prensa || Nuestra nueva página de inicio


Carpeta PAHO/WHO Scientific and technical material

Documentos

pdf Developing pharmacy practice. A focus on patient care, 2006  Publicado Popular

656 descargas

pdf Implementing the third WHO Medicines Strategy 2008–2013  Publicado Popular

2082 descargas

pdf PANDRH Technical Report Nº 8. Framework for Implementation of Equivalence Requirements for Pharmaceutical Products  Publicado Popular

3207 descargas

pdf Pharmaceutical Situation in the Caribbean: Factbook on Level I Monitoring Indicators 2007  Publicado Popular

3580 descargas

pdf The Pharmaceutical situation in the Caribbean: Monitoring indicators 2010-2012  Publicado Popular

3207 descargas

The data presented are related to the pharmaceutical situation of 11 Caribbean countries and two United Kingdom Overseas Territories (UKOTs)- Antigua and Barbuda, Barbados, Dominica, Grenada, Guyana, Jamaica, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, British Virgin Islands and Turks and Caicos Islands- using information collected from 2010 to 2012 within the framework of the Pharmaceutical Sector Country Profiles project. The percentages in the report have been calculated in relation to the total number of respondents for each question. The Caribbean data are compared with that for the Americas region (with a total of 28 participating countries/UKOTs), where possible. Only the information provided by the countries along with an official signed endorsement were included in the individual pharmaceutical country profile and in this publication.